Escape Room Experience: LDL-Lowering Therapy and Beyond - Applying Advances to Patient Care
Lowering LDL-C effectively and safely is crucial to prevent and lower the risk of adverse cardiovascular events, however, LDL-C goal achievement remains suboptimal, including in high-risk and very high-risk patients.
Category
  • CMHC
Format
  • Video
Credits
  • 1.25 ABIM MOC and AMA PRA Category 1 Credit
  • 1.25 ACPE Pharmacy
  • 1.25 AMA PRA Category 1 Credit
  • 1.25 ANCC
  • 1.25 CDE
  • 1.25 Participation
Webcast: Identifying and Addressing Elevated Sodium Intake to Decrease Cardiovascular Risk
Increased sodium intake is considered to be a leading risk factor for cardiovascular disease (CVD), Additionally, the impact of commonly-used medications with high sodium content contributes to this burden.  As such, it is important to address the risk of increased sodium i
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation
Hidradenitis Suppurativa Clinician-Patient Summit
Hidradenitis suppurativa has significant impacts on patients’ quality of life, however, it remains underdiagnosed, misdiagnosed, or incorrectly treated.  Until recently, there was a scarcity of evidence about long-term management strategies and no evidence-based consensus guidelines.  The updated
Category
  • LivDerm
  • TME
Format
  • Video
Credits
  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit
  • 2.00 ANCC
  • 2.00 Participation
Advances in Managing Eosinophilic Esophagitis: Tips for the Practicing Clinician
Eosinophilic esophagitis (EoE), a chronic, debilitating illness that is mediated via cells of the immune system (eosinophils) eliciting T-helper 2 (Th2) cell mediated inflammation, affects several people globally and imparts significant impact on the quality of life (QoL) o
Category
  • TME
Format
  • Self-study / Enduring
  • Webinar recorded
Credits
  • 0.50 AMA PRA Category 1 Credit
  • 0.50 Participation
Ace the Case Challenge Series: Sodium Intake and CV Risk
Increased sodium intake is considered to be a leading risk factor for cardiovascular disease (CVD), Additionally, the impact of commonly-used medications with high sodium content contributes to this burden.  As such, it is important to address the risk of increased sodium i
Category
  • CMHC
Format
  • Self-study / Enduring
Credits
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 ANCC
  • 1.50 Participation
AhR Agonists for Psoriasis: A Novel Mechanism for Treatment of PsO
Psoriasis is a difficult disease to manage due to a variety of factors including fluctuations in disease severity, limited treatment options, and a limited understanding of the pathogenesis of disease.
Category
  • LivDerm
  • TME
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation
The Role of TAVR in Improving Outcomes in Women with Aortic Stenosis: Assessing the Evidence and Clinical Pearls
Despite advances, there are significant gaps in the diagnosis and treatment of aortic stenosis (AS) in women.
Category
  • CMHC
Format
  • Video
Credits
  • 0.75 ACPE Pharmacy
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC
  • 0.75 Participation
Sleep, Sodium, and CVD - A Cardiology Perspective
Increased sodium intake is considered to be a leading risk factor for cardiovascular disease (CVD), including in the development of hypertension and risk of adverse cardiovascular outcomes. Additionally, the impact of commonly-used medications with high sodium content contributes to this burden.
Category
  • CMHC
Format
  • Self-study / Enduring
Credits
  • 2.25 ACPE Pharmacy
  • 2.25 AMA PRA Category 1 Credit
  • 2.25 ANCC
  • 2.25 Participation
New Hope on the Horizon - Advances in the Diagnosis and Treatment of Idiopathic Hypersomnia
Idiopathic hypersomnia (IH) is a chronic neurological disorder that has significant impacts on daily functioning, with symptoms that include, but often go beyond excessive daytime sleepiness (EDS).
Category
  • CMHC
Format
  • Self-study / Enduring
Credits
  • 1.75 ACPE Pharmacy
  • 1.75 AMA PRA Category 1 Credit
  • 1.75 ANCC
  • 1.75 Participation
18th Annual CMHC On Demand
The recordings from the 18th Annual meeting are now available. 
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • 19.25 ACPE Pharmacy
  • 19.25 AMA PRA Category 1 Credit
  • 19.25 ANCC
  • 19.25 CDE
  • 19.25 Participation

Pages